Dilution refolding of consensus interferon (C-IFN) had a limit on final concentration not exceeding 0.1 mg ml(-1) in order to achieve specific activity of 2.2 x 10(8) U mg(-1). Addition of polyethylence glycol (PEG) only gave a marginal improvement on the specific activity. Hydrophobic interaction chromatography (HIC) was tried but a simple step-wise elution could not refold the protein. Successful refolding was achieved by gradient elution with the decreasing of guanidine-hydrochloride (guanidine-HCl) concentration. The column was packed with a commercially available HIC medium that was designed for protein separation. Polyethylene glycol was found to possess better effect on the column than in the dilution for promotion of correct refoldi...
A dual-gradient ion-exchange chromatography (IEC) refolding process has been successfully applied to...
New methods for the chromatographic isolation of inclusion bodies directly from crude Escherichia co...
The efforts made to-date to alleviate the downstream challenges faced by the biopharmaceutical indus...
Efficient refolding of recombinant proteins in the forms of inclusion bodies at higher concentration...
Chromatographic columns packed with commercially available hydrophobic interaction chromatography (H...
Dilution refolding of recombinant consensus IFN (interferon) from inclusion bodies suffers from low ...
Affibody® molecules are small affinity proteins with great opportunities in the application of biote...
Background: Hydrophobic interaction chromatography (HIC) most commonly requires experimental determi...
Most proteins and large polypeptides have hydrophobic regions at their surface. These hydrophobic ‘p...
Traditional PEGylation strategy of peptide and protein usually results in heterogeneous products wit...
A new dual-gradient ion exchange chromatographic method was developed to improve the refolding yield...
The effect of different kosmotropic/chaotropic salt systems on retention characteristics of intact p...
This study describes and adaptation of hydrophobic interaction chromatography (HIC) that can be used...
peer reviewedWe describe a liquid chromatography method development approach for the separation of i...
Hydrophobic interaction chromatography (HIC) and other capture media are typically produced by graft...
A dual-gradient ion-exchange chromatography (IEC) refolding process has been successfully applied to...
New methods for the chromatographic isolation of inclusion bodies directly from crude Escherichia co...
The efforts made to-date to alleviate the downstream challenges faced by the biopharmaceutical indus...
Efficient refolding of recombinant proteins in the forms of inclusion bodies at higher concentration...
Chromatographic columns packed with commercially available hydrophobic interaction chromatography (H...
Dilution refolding of recombinant consensus IFN (interferon) from inclusion bodies suffers from low ...
Affibody® molecules are small affinity proteins with great opportunities in the application of biote...
Background: Hydrophobic interaction chromatography (HIC) most commonly requires experimental determi...
Most proteins and large polypeptides have hydrophobic regions at their surface. These hydrophobic ‘p...
Traditional PEGylation strategy of peptide and protein usually results in heterogeneous products wit...
A new dual-gradient ion exchange chromatographic method was developed to improve the refolding yield...
The effect of different kosmotropic/chaotropic salt systems on retention characteristics of intact p...
This study describes and adaptation of hydrophobic interaction chromatography (HIC) that can be used...
peer reviewedWe describe a liquid chromatography method development approach for the separation of i...
Hydrophobic interaction chromatography (HIC) and other capture media are typically produced by graft...
A dual-gradient ion-exchange chromatography (IEC) refolding process has been successfully applied to...
New methods for the chromatographic isolation of inclusion bodies directly from crude Escherichia co...
The efforts made to-date to alleviate the downstream challenges faced by the biopharmaceutical indus...